Eargo and hearX Merge to Create LXE Hearing: Revolutionizing the Hearing Aid Market
SAN JOSE, Calif., March 31, 2025 /PRNewswire/ — Two leading national hearing health brands, Eargo and hearX, have joined forces to establish LXE Hearing, a new company aimed at making high-quality hearing aids more accessible and affordable for the estimated 44 million American adults with hearing loss. This merger marks a significant milestone in the over-the-counter hearing aid space since the FDA’s 2022 regulations that permitted the sale of such devices.
LXE Hearing has received a substantial $100 million investment from Patient Square Capital, a renowned healthcare investment firm. The collaboration between Eargo and hearX brings together decades of experience in hearing health innovation, combining Eargo’s expertise in design, device features, sound technology, and mobile platforms with hearX’s acclaimed Lexie hearing aids.
The newly formed LXE Hearing will operate as a unified entity with Eargo and Lexie Hearing as its established consumer hearing aid brands. With a collective 25 years of experience, LXE Hearing aims to set a new industry standard by integrating the best features of both brands and enhancing the overall customer experience. The company will merge product technology platforms and Customer Relationship Management systems to streamline operations for all business partners.
Grounded in clinical excellence, LXE Hearing leverages the exceptional clinical standards and scientific research of both Eargo and hearX. With over 52 peer-reviewed articles validating their technology and 68 patents, the company is committed to delivering cutting-edge solutions for individuals with hearing loss.
Nic Klopper, CEO and co-founder of hearX, will lead LXE Hearing as CEO, while Bill Brownie, Eargo’s COO and interim CEO, will assume the role of COO. Klopper emphasized the shared mission of creating inclusive hearing health solutions for everyone, highlighting the complementary strengths of Eargo’s design and clinical quality with hearX’s innovative products and mobile app.
Eargo, a pioneer in direct-to-consumer hearing aids in the U.S., is known for its virtually invisible design and decade-long success in digital hearing detection. In contrast, hearX’s Lexie Hearing division quickly rose to become the top OTC hearing aid brand in the U.S. With a focus on accessibility and affordability, the merger between Eargo and hearX aims to cater to the needs of millions of Americans experiencing hearing loss.
Patient Square Capital’s additional $100 million investment reflects confidence in the direct-to-patient hearing market, which is reshaping the traditional prescription model. The unique go-to-market approach and innovative technology of LXE Hearing are poised to provide unparalleled solutions to individuals in need of hearing care.
In conclusion, LXE Hearing’s merger signifies a significant step towards revolutionizing the hearing aid market by combining the strengths of two industry leaders. The company’s commitment to clinical excellence, cutting-edge technology, and customer-centric approach will undoubtedly benefit millions of individuals with hearing loss. For more information about LXE Hearing, visit www.lxehearing.com. Join us in embracing a new era of hearing health innovation.
